Investigation of the Effectiveness of Rehabilitation Using the HUBER 360 Tool to Reduce the Risk of Falls in People in Pathological Situations Requiring Functional Rehabilitation
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Liege
- Enrollment
- 32
- Locations
- 2
- Primary Endpoint
- Risk of falls, in seconds
Study Overview
Brief Summary
Aim: The aim of the present study was to analyse the effects of training performed on a rotating, motorised platform (the Huber/SpineForce device from LPG Systems, Valence, France) intended to reduce the risk of falls.
Subjects: any patient 1) benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF, Belgium; 2) presenting a pathological situation justifying functional rehabilitation with HUBER 360®; 3) presenting any pathology not constituting an exclusion criterion; 4) giving informed consent to research will be include in this 8-week interventional trial.
Design: randomized open-label trial. Patients will be randomized into the intervention group (HUBER trainig, 45 minutes of training, twice a week during 8 weeks) or in the control group (standard care).
Outcomes: the effect of the training will be measured on the Time-Up-and-Go test, on the Short-Physical performance battery test and on quality of life.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF
- •Patient presenting a pathological situation justifying functional rehabilitation with HUBER 360®
- •Patient presenting any pathology not constituting an exclusion criterion
- •Patient giving informed consent to research.
Exclusion Criteria
- •Cardiac or respiratory or neurological or rheumatological disease incompatible with physical activity ;
- •Joint inflammation;
- •Rheumatic disease in acute phase;
- •Recent trauma, infection of the musculoskeletal system;
- •Venous thrombosis ;
- •Discopathy in acute phase;
- •Neuropsychological problems that do not allow to integrate the instructions or other serious psychological problems;
- •Cardiovascular diseases and any progressive, chronic, counter-indicative disease;
- •Large anatomical deformities.
Outcomes
Primary Outcomes
Risk of falls, in seconds
Time Frame: 8 weeks
Measured with Timed-Up-and Go test
Secondary Outcomes
- Quality of life, measured with the Short Form-36 questionnaire(8 weeks)
- Physical performance(8 weeks)
- Utility score using the EuroQol- 5 Dimension questionnaire(8 weeks)
Investigators
Charlotte Beaudart
Principal investigator
University of Liege